This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#(b)(4).
|
It was reported that a patient underwent an idiopathic ventricular tachycardia (idvt) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced cardiac tamponade that required pericardiocentesis and prolonged hospitalization.They had done 4 ablations, then it was observed the patient's pressure was low.Pericardial effusion was discovered by intracardiac echocardiography (ice) and the medical intervention provided to the patient was that she was monitored all day.Echo came in and they didn't rule the effusion big enough to need a pericardiocentesis, but then her pressure wasn't really recovering and she wasn't able to come off pressure support way later in the evening the patient was "tapped"(pericardiocentesis).Additional information received indicated there was fluid around right and left ventricle but ablation was being done in the left ventricle.The physician's opinion on the cause of this adverse event is the ablation but uncertain as only 4 lesions were performed with little force.Transseptal puncture was performed with a baylis versacross fixed sheath.No steam pop was confirmed.Patient required extended hospitalization.Patient has fully recovered.
|
On 29-apr-2024, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|